Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells.


Surgical resection of gastric cancer has made significant progress, but majority of patients with advanced gastric cancer face relapse and die within five years. In this study, the antitumor activity of ex vivo expanded T cells against the human gastric cancer was evaluated in vitro and in vivo. Human peripheral blood mononuclear cells were cultured with IL… (More)
DOI: 10.1007/s12272-010-1111-7



Citations per Year

Citation Velocity: 15

Averaging 15 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.